title: The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.
abstract: Human cocaine users report that the initial "high" produced by cocaine administration is followed by an anxiogenic "crash". Given that cocaine has such robust and opposing properties, it is likely that both positive and negative effects of cocaine contribute to an individual's motivation to administer the drug. Despite this likelihood, the neurobiology underlying cocaine's dual processes remains unclear. While much literature supports a role for dopamine (DA) in cocaine reward, it is uncertain if DA also contributes to the drug's negative effects. Our laboratory has extensively utilized a modified conditioned place test to explore cocaine's opponent processes. In this paradigm rats develop conditioned place preferences (CPPs) for an environment paired with the immediate/positive effects of cocaine, and conditioned place aversions (CPAs) for an environment paired with the delayed/negative effects present 15-min after i.v. injection. In the current study rats were conditioned to associate an environment with either the immediate or delayed effects of i.v. cocaine (1mg/kg/0.1ml) 3h after i.p. pre-treatment with either the DA D1/D2 receptor antagonist cis-flupenthixol (0.5mg/kg/ml) or saline vehicle. As expected, vehicle-treated control animals developed the normal pattern of CPPs for cocaine's immediate effects or CPAs for the delayed effects of cocaine. However, while DA receptor antagonism prevented the expression of cocaine CPPs it did not alter the expression of cocaine-induced CPAs. These data confirm a role for DA transmission in cocaine reward but suggest that different neural pathways mediate the drug's negative/anxiogenic properties.
authors.affiliation: Behavioral Pharmacology Laboratory, Department of Psychological and Brain Sciences, University of California, Santa Barbara, CA 93106-9660, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Wenzel
authors.forename: Zu-In
authors.initials: ZI
authors.lastname: Su
authors.forename: Kerisa
authors.initials: K
authors.lastname: Shelton
authors.forename: Hiram M
authors.initials: HM
authors.lastname: Dominguez
authors.forename: Victoria A
authors.initials: VA
authors.lastname: von Furstenberg
authors.forename: Aaron
authors.initials: A
authors.lastname: Ettenberg
mesh_terms: D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology*; D005475:Flupenthixol / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects; D008297:Male; D009042:Motivation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D018492:Dopamine Antagonists; D005475:Flupenthixol; D003042:Cocaine
keywords: Aversion; Cocaine; Conditioned place preference; Dopamine; Reward; cis-Flupenthixol